Missing/wrong data?
Log in to edit
Osimertinib benefit in EGFR-mutant NSCLC patients with T790M-mutation detected by circulating tumour DNA.
scientific article published on 18 January 2017
Author/s
author: Andrew Lawson, Maria-Virginia Bluthgen
Work details
Publication date
January 18, 2017
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.